ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC

Medtech · Private

Smart Photodynamic Therapy (S-PDT) platform for targeted treatment of acne via selective sebocyte destruction

acis-us.com →
Grants
$1.3M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$10K
1 award · Health and Human S
#631 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cells$148,067
Federal grantDepartment of Health and Human Services · Phase II · Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cells$1,193,945
Federal contractDepartment of Health and Human Services · Lab Supplies$9,980
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
628DuraStat LLC$11K$6.8M
629Stimlabs LLC$10K$10M
630CREOSALUS INC.$10K—
631ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC$10K—
632InCellDx, Inc.$10K$9.5M
633Insightra Medical, Inc.$9K$20M
634OSMIC ENTERPRISES, INC.$9K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.